InvestorsHub Logo
Followers 23
Posts 1725
Boards Moderated 0
Alias Born 09/03/2015

Re: laraz5 post# 15862

Thursday, 01/25/2018 7:41:26 PM

Thursday, January 25, 2018 7:41:26 PM

Post# of 21373
I can't wait til phase I trials are concluded. It's guaranteed to yield positive results. Prolanta is essentially the same exact drug as Somavert, Which happens to be FDA approved. Prolanta will atleast get to phase III with a high probability of an FDA approval.

Scientists have been trying for years to counteract human prolactin with various drugs and most notably bromocriptine, because they know it plays a huge role in the development and spread tumors as well as chemo resistance. Prolanta is the first pure prolactin antagonist designed and modeled off of Somavert the first pure growth hormone antagonist.

Growth hormone and prolactin share 49 identical amino acid residues along their peptide chains. Somavert aka G120R is an amino acid substitution of 120th amino acid residue position and Prolanta aka G129R is an amino acid substitution of the 129th amino acid residue position. These are 2 of the 49 identical positions that are shared by hGH and hPRL.

Knowing that a near identical drug, Somavert, has successfully made it through FDA trials as a pure hGH antagonist, it's almost a guarantee that Prolanta will make it through FDA trials as a pure hPRL antagonist. Both hGH and hPRL are pituitary hormones that are part of the same cytokine receptor family.
A near identical drug working on a near identical hormone. Smells like Prolanta success!!!

BIG THINGS COMING!!!

GO ONCX!!!
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.